Long-Term Outcome of Intact Abdominal Aortic Aneurysm After Endovascular or Open Repair

医学 围手术期 危险系数 腹主动脉瘤 腔内修复术 倾向得分匹配 外科 优势比 置信区间 回顾性队列研究 动脉瘤 队列 主动脉瘤 存活率 内科学
作者
Jasmin Epple,Yuliya Svidlova,Thomas Schmitz‐Rixen,Dittmar Böckler,Neelam Lingwal,Reinhart T. Grundmann
出处
期刊:Vascular and Endovascular Surgery [SAGE Publishing]
卷期号:57 (8): 829-837 被引量:3
标识
DOI:10.1177/15385744231178130
摘要

Endovascular aortic aneurysm repair (EVAR) has been established as a standard treatment option for intact abdominal aortic aneurysm (iAAA) and gained importance due to a lower perioperative mortality than open repair (OAR). However, whether this survival advantage can be maintained or if OAR is beneficial in terms of long-term complications and reinterventions remains questionable.In this retrospective cohort study data from patients undergoing elective EVAR or OAR for iAAAs in the years 2010-2016 was analyzed. The patients were followed through 2018.In the propensity score matched cohorts the perioperative and long-term outcomes of the patients were assessed. We identified 20 683 patients undergoing elective iAAA repair (76.4% EVAR). The propensity matched cohorts included 4886 pairs of patients.The perioperative mortality was 1.9% for EVAR and 5.9% for OAR (P = <.001). The perioperative mortality was mainly influenced by patients age (Odds-Ratio (OR):1.073, confidence interval (CI):1.058-1.088, P ≤ .001) and OAR (OR:3.242, CI:2.552-4.119, P ≤ .001). The early survival benefit after endovascular repair persisted for approximately 3 years (estimated survival EVAR 82.3%, OAR 80.9%, P = .021). After that time the estimated survival curves were similar. After 9 years the estimated survival was 51.2% after EVAR as compared to 52.8% after OAR (P = .102). The operation method didn't influence long-term survival significantly (Hazard-Ratio (HR): 1.046, CI: .975-1.122, P = .211). The vascular reintervention rate was 17.4% in the EVAR cohort and 7.1% in the OAR cohort (P ≤ .001).EVAR has a significantly lower perioperative mortality than OAR, a survival benefit that lasts up to 3 years after intervention. Thereafter, no significant difference in survival was observed between EVAR and OAR. The decision between EVAR or OAR may depend on patient preference, surgeons' experience, and the institutions' ability to handle complications.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
雪山飞龙发布了新的文献求助10
2秒前
傲娇衬衫发布了新的文献求助10
2秒前
2秒前
2秒前
yuzhi发布了新的文献求助20
2秒前
3秒前
有几颗荔枝完成签到,获得积分20
3秒前
3秒前
ZZ发布了新的文献求助10
3秒前
qiuwuji完成签到,获得积分10
3秒前
Dr_Li1741完成签到,获得积分10
4秒前
4秒前
李健的粉丝团团长应助zty采纳,获得10
4秒前
热心晓丝发布了新的文献求助10
5秒前
霸王爱吃面完成签到,获得积分10
6秒前
mukou完成签到,获得积分10
6秒前
6秒前
6秒前
1tw发布了新的文献求助10
7秒前
失眠海云发布了新的文献求助30
7秒前
7秒前
37发布了新的文献求助10
8秒前
Hello应助承蒙采纳,获得10
8秒前
8秒前
棍棍来也完成签到,获得积分10
8秒前
悦耳的闭月完成签到,获得积分10
8秒前
8秒前
8秒前
8秒前
盒子发布了新的文献求助10
9秒前
9秒前
藏杨同学给藏杨同学的求助进行了留言
9秒前
9秒前
神勇友易发布了新的文献求助10
9秒前
猫猫完成签到,获得积分10
10秒前
开心涛完成签到,获得积分10
10秒前
没有鱼发布了新的文献求助10
10秒前
桐桐应助jxzou采纳,获得10
10秒前
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
PowerCascade: A Synthetic Dataset for Cascading Failure Analysis in Power Systems 2000
Picture this! Including first nations fiction picture books in school library collections 1500
Signals, Systems, and Signal Processing 610
Unlocking Chemical Thinking: Reimagining Chemistry Teaching and Learning 555
CLSI M100 Performance Standards for Antimicrobial Susceptibility Testing 36th edition 400
Cancer Targets: Novel Therapies and Emerging Research Directions (Part 1) 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6362814
求助须知:如何正确求助?哪些是违规求助? 8176643
关于积分的说明 17229522
捐赠科研通 5417707
什么是DOI,文献DOI怎么找? 2866811
邀请新用户注册赠送积分活动 1843993
关于科研通互助平台的介绍 1691695